Impact Factor
4.39
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.06
13,519 total citations
h5-index
77
h5 depth signal
Cited share
88.3%
2,539 of 2,877
Total citations
13,519
Citation footprint
Metric signal
4.93
External metric anchor
Self-citation
2.3%
314 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
6,896
United States
1,828
Japan
1,010
Germany
908
United Kingdom
681
Citing Fields of Research
Oncology
5,314
Breast Cancer
2,221
Liver & Colon Cancer
2,033
Cancer & Development
1,889
Immunology
1,716
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
21,282
Articles tracked across the journal lifetime
Indexed publication set
2,877
2,539 cited publications
Last 12 months
2,143
178.6 publications/month
Open access share
99.9%
2,141 OA publications in the last year
Leading citing country
China
6,896 citing publications
Leading citing field
Oncology
5,314 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1, 2001-
v1, 2001-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Lung Cancer
Liver & Colon Cancer
Immunology
Digestive Disorders
Broad Categories
Neoplasms
Digestive Disorders
Liver & Colon Cancer
Immunology
Lung Cancer
Breast Cancer
Oncology
Noncoding RNA
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
05
DOI 10.1186/s12885-026-17160-2
Open DOI
Digital phenotyping for monitoring mental health outcomes in patients with cancer: a scoping review
06
07
DOI 10.1186/s12885-026-17184-8
Open DOI
Stigmasterol suppresses glioblastoma growth through mitochondrial dysfunction and oxidative stress
08
09
10
DOI 10.1186/s12885-026-17176-8
Open DOI
Plasma biomarkers and long-term survival in head and neck squamous cell carcinoma patients: insights from EGF, VEGF, IL-4, IL-6, IL-8 and MCP-1 at diagnosis
Background: The acute-phase cascade (APC) has been correlated with outcome in many different cancers, including head and neck squamous cell carcinoma (HNSCC). A main driver of the APC is cytokines. We have studied systemic acute-phase so...
Bibliographical & Catalog Notes
Title from BioMed Central archive volume screen (viewed on Feb. 14, 2002).
Articles are added consecutively to the current annual v.
Text (electronic journal) in HTML and PDF formats.
System requirements: Internet connectivity, World Wide Web browser.
Mode of access: Internet.